BioLife Solutions (BLFS) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order on October 5, 2026; September 3, 2026 was the record date, and a quorum was declared.

• 48,923,333 common shares were outstanding and entitled to vote; at least 16,307,778 shares, one-third of the total, were represented in person virtually or by proxy.

• Polls closed at 9:06 A.M. Eastern Time after stockholders had the opportunity to vote online or by proxy.

Specific resolutions to be voted on

• Proposal 1 sought adoption of the July 21, 2026 merger agreement with Repligen and the two merger subsidiaries.

• Proposal 2 sought non-binding approval of merger-related compensation for named executive officers.

• Proposal 3 sought approval to adjourn the meeting if needed, including to solicit additional merger-agreement proxies.

Board and executive committee updates

• The board unanimously recommended voting in favor of all three proposals.